Tirzepatide
COMMIT-UC
Eli Lilly · Phase 3 · Recruiting · Enrollment 350
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Mirikizumab + Tirzepatide | Obesity or overweight | n/r | n/r | n/r | n/r |
| Mirikizumab + Placebo | Obesity or overweight | n/r | n/r | n/r | n/r |
Disease Pipeline Tools Obesity
Obesity
Programs, trials, and reported weight change for obesity and overweight.
Tirzepatide
Eli Lilly · Phase 3 · Recruiting · Enrollment 350
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Mirikizumab + Tirzepatide | Obesity or overweight | n/r | n/r | n/r | n/r |
| Mirikizumab + Placebo | Obesity or overweight | n/r | n/r | n/r | n/r |